Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew

IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2017: 152.94

Open Access
See all formats and pricing
More options …
Volume 10, Issue 1


Volume 10 (2015)

Quick and effective method of bone marrow mesenchymal stem cell extraction

Zivile Gudleviciene / Gabrielis Kundrotas
  • National Cancer Institute, Biobank Santariskiu 1, 08660 Vilnius, Lithuania Vilnius University, Faculty of Natural Sciences M.K. Ciurlionio 21/27, 03101 Vilnius
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Regina Liudkeviciene / Jelena Rascon
  • Children‘s Hospital, Affiliate of Vilnius Unversity Hospital Santariskiu Klinikos, Children Heamatology and Transplantation Center Santariskiu 7, 08406, Vilnius, Lithuania
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Marcin Jurga
  • Cryo-Save Labs NV, Attn. The Cell Factory (R&D department) Galileilaan 19, B-2845 Niel, Belgium
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2014-10-08 | DOI: https://doi.org/10.1515/med-2015-0008


Background. Mesenchymal stem cells (MSCs) are currently exploited in numerous clinical trials to investigate their potential in immune regulation, hematopoesis or tissue regeneration. The most common source of MSCs for clinical use is human bone marrow. To generate sufficient numbers of cells relevant to clinical use in most cases the high volumes (20-50 ml) of bone marrow aspirates are taken. Methods. In this pilot study, 8 healthy bone marrow donors were included. Two different MSC extraction methods were evaluated: MSCs extraction from 60 ml of bone marrow using density gradient and MSCs extraction from 6 ml using red blood cell (RBC) lysis. Results. Our results showed that after RBC lysis the efficient amount of human MSCs can be isolated from 10 times less bone marrow volume (6 ml). Moreover, using small volume of bone marrow the adequate therapeutical dose of MSCs could be achieved during similar period of time (3-4 weeks). In conclusion, we have shown that MSCs isolation using RBC lysis is an effective and more advantageous method in comparison to standard MSCs isolation using density-gradient. Using RBC lysis from small volume of bone marrow the same amount of MSCs were obtained as usually using large volume and density-gradient.

Keywords : Bone marrow; Cell therapy; Ficoll gradient; Mesenchymal stem cells; Red blood cell lysis


  • [1] Beyer N.N., Meirelles S.L., Mesenchymal Stem Cells: Isolation, In Vitro Expansion and Characterization, In: Wobus A.M. and Boheler K.R. (Eds), Stem cells, vol. 174, Handbook of experimental pharmacology, New York: Springer-Verland Berlin Heidelberg, 2006, 249-282Google Scholar

  • [2] Bieback K., Schallmoser K., Kluter H., Strunk D., Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells, Transfus. Med. Hemother., 2008, 35(4), 286-294Web of ScienceGoogle Scholar

  • [3] Jung S., Panchalingam K.M., Rosenberg L., Behie L.A., Ex vivo expansion of human mesenchymal stem cells in defined serum-free media, Stem Cells Int., 2012, 2012:123030, DOI: 10.1155/2012/123030Web of ScienceGoogle Scholar

  • [4] Thirumala S., Goebel W.S., Woods E.J., Clinical grade adult stem cell banking, Organogenesis, 2009, 5(3), 143-154Web of ScienceCrossrefGoogle Scholar

  • [5] Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., at al., Mesenchymal stem cells for treatment of steroidresistant, severe, acute graft-versus-host disease: a phase II study, Lancet, 2008, 371(9624), 1579-1586Google Scholar

  • [6] Venkataramana N.K., Kumar S.K., Balaraju S., Radhakrishnan R.C., Bansal A., Dixit A., et al., Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson’s disease, Transl. Res., 2010, 155(2), 62-70CrossrefWeb of ScienceGoogle Scholar

  • [7] Lee H., Park J.B., Lee S., Baek S., Kim H., Kim S.J., Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study, J. Transl. Med., 2013, 11-96Web of ScienceGoogle Scholar

  • [8] Hass R., Kasper C., Bohm S., Jacobs R., Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC, Cell Commun. Signal., 2011, 9-12Web of ScienceGoogle Scholar

  • [9] Cooper K., Viswanathan C., Establishment of a mesenchymal stem cell bank, Stem Cells Int., 2011, 2011, 905621Web of ScienceGoogle Scholar

  • [10] Horn P., Bork S., Diehlmann A., Walenda T., Eckstein V., Ho A.D., et al., Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis, Cytotherapy, 2008, 10(7), 676-685CrossrefWeb of ScienceGoogle Scholar

  • [11] Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 2006, 8(4), 315-317CrossrefGoogle Scholar

  • [12] Buhring H.J., Treml S., Cerabona F., de Zwart P., Kanz L., Sobiesiak M., Phenotypic characterization of distinct human bone marrow-derived MSC subsets, Ann. N.Y. Acad. Sci., 2009, 1176, 124-134CrossrefGoogle Scholar

  • [13] Ringden O., Le Blanc K., Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages, Best Pract. Res. Clin. Haematol., 2011, 24(1), 65-72Web of ScienceCrossrefGoogle Scholar

  • [14] Fennema E.M., Renard A.J., Leusink A., van Blitterswijk C.A., de Boer J., The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells, Acta Orthop., 2009, 80(5), 618-621Web of ScienceCrossrefGoogle Scholar

  • [15] Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., et al., Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 2004, 363(9419), 1439-1441Google Scholar

  • [16] Sensebe L., Bourin P., Tarte K., Good manufacturing practices production of mesenchymal stem/stromal cells, Hum. Gene Ther., 2011, 22(1), 19-26CrossrefWeb of ScienceGoogle Scholar

  • [17] Horn P., Bokermann G., Cholewa D., Bork S., Walenda T., Koch C., at al., Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells, Cytotherapy, 2010, 12(7), 888-898Web of ScienceCrossrefGoogle Scholar

  • [18] Fekete N., Gadelorge M., Furst D., Maurer C., Dausend J., Fleury- Cappellesso S., et al., Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components, Cytotherapy, 2012, 14(5), 540-554Web of ScienceGoogle Scholar

  • [19] Fekete N., Rojewski M.T., Furst D., Kreja L., Ignatius A., Dausend J., et al., GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC, PLoS One, 2012, 7(8), e43255Google Scholar

  • [20] Schrezenmeier H., Seifried E., Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?, Vox. Sang., 2010, 99, 1-15Web of ScienceGoogle Scholar

  • [21] Otsuru S., Hofmann T.J., Olson T.S., Dominici M., Horwitz E.M., Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device, Cytotherapy, 2013, 15(2), 146-153Web of ScienceCrossrefGoogle Scholar

About the article

Received: 2014-03-21

Accepted: 2014-06-29

Published Online: 2014-10-08

Published in Print: 2015-01-01

Citation Information: Open Medicine, Volume 10, Issue 1, ISSN (Online) 2391-5463, DOI: https://doi.org/10.1515/med-2015-0008.

Export Citation

© 2015 Z. Gudleviciene et al,. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Natalia M. Yudintceva, Yulia A. Nashchekina, Nataliya A. Mikhailova, Tatiana I. Vinogradova, Petr K. Yablonsky, Anna A. Gorelova, Alexandr N. Muraviov, Andrey V. Gorelov, Igor A. Samusenko, Boris P. Nikolaev, Ludmila Y. Yakovleva, and Maxim A. Shevtsov
Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2019
Nimshitha Pavathuparambil Abdul Manaph, Mohammed Al-Hawaas, Larisa Bobrovskaya, Patrick T. Coates, and Xin-Fu Zhou
Stem Cell Research & Therapy, 2018, Volume 9, Number 1
Sangeetha Kannan, Sujoy K. Dhara, and Jyotirmoy Ghosh
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2018
Mohamed Y. Salem, Nahla El-Eraky El-Azab, and Rania Ibrahem
The Egyptian Journal of Histology, 2016, Volume 39, Number 1, Page 74

Comments (0)

Please log in or register to comment.
Log in